Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent?

References

• Pickering TG, Coats A, MaIlion JM, Mancia G, Verdecchia P. Blood pressure monitoring. Task force V: White-coat hypertension. Blood Press Monit 1999; 4: 333–41.
   PubMedGoogle Scholar
• Soma J, Aakhus S, Dahl K, et al. Hemodynamics in white coat hypertension compared to ambulatory hypertension and normotension. Am J Hypertens 1996; 9: 1090–8.
   PubMedGoogle Scholar
• Pickering TG, James GD, Boddie C, et al. How common is white coat hypertension. JAMA 1988; 259: 225–8.
   PubMed Web of Science ®Google Scholar
• White WB, Schulman P, McCabe E, et al. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873–7.
   PubMed Web of Science ®Google Scholar
• Cardillo C, De Felice F, Campia U, et al. Psychological reactivity and cardiac end organ changes in white coat hypertension. Hypertension 1993; 21: 836–44.
   PubMedGoogle Scholar
• Hoegholm A, Bang LE, Kristensen KS, et al. Microalbumi-nuria in 411 untreated individuals with established hyper-tension, white coat hypertension and normotension. Hyper-tension 1994; 24: 101–5.
   Google Scholar
• Björklund K, Lind L, Vessby B, Andren B, Lithe11 H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow up. Circulation 2002; 106: 63.
   Google Scholar
• Julius S, Mejia A, Jones K, et al. 'White coat' versus 'sustained' borderline hypertension in Tecimseh, Michigan. Hypertension 1990; 16: 617–23.
   PubMed Web of Science ®Google Scholar
• Weber MA, Neutel JM, Smith DHG, et al. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90: 2291–8.
   PubMedGoogle Scholar
• American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 1992; 5: 207–9.
   PubMed Web of Science ®Google Scholar
• Ramsay LE, Williams B, Johnston GD, et al. BHS Guidelines for the management of hypertension: report of third working party of the British Hypertension Society. J Hum Hypertens 1999; 13: 569–92.
   PubMed Web of Science ®Google Scholar
• Chalmers J, MacMahon S, Mancia G, et al. WHO-ISH Hypertension Guidelines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hyper-tens 1999; 17: 151–85.
   Google Scholar
• O'Brien E, Waeber B, Parati G, Staessen J, Myers MJ on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531–6.
   Google Scholar
• O'Brien E, Coats A, Owens P, et al. Use and interpretation of Ambulatory blood pressure monitoring: recommenda-tions of the British Hypertension Society. BMJ 2000; 320: 1128–34.
   PubMed Web of Science ®Google Scholar
• Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 2002; 39: 1020–5.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardio-graphic assessment of left ventricular hypertrophy: com-parison to necropsy findings. Am J Cardiol 1986; 57: 450–8.
   PubMed Web of Science ®Google Scholar
• Walsh JB. Hypertensive retinopathy. Description, classifica-tion, and prognosis. Ophthalmology 1982; 89: 1127–31.
   Google Scholar
• Smilde TJ, van den Berkmortel FWPJ, Boers GHJ, et al. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. Arterioscler Thromb 1998; 18: 1958–63.
   PubMed Web of Science ®Google Scholar
• Hoeks APG, Brands PJ, Smeets FAM, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 1990; 16: 121–8.
   PubMed Web of Science ®Google Scholar
• Parati G, Ulian L, Santucciu C, Omboni S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998; 31: 1185–9.
   Google Scholar
• Guidelines Comittee. 2003 European Society of Hyperten-sion - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53.
   Google Scholar
• Cardillo C, De Felice F, Campia U, Folli G. Psychophysio-logical reactivity and cardiac end-organ changes in white coat hypertension. Hypertension 1993; 21: 836 /1/I.
   Google Scholar
• Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993; 22: 826–31.
   PubMed Web of Science ®Google Scholar
• Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux R. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131: 564–72.
   PubMed Web of Science ®Google Scholar
• Weber MA, Neutel JM, Smith DHG, Graettinger WF. Diagnosis of mild hypertension by ambulatory blood pressure monitoring. Circulation 1994; 90: 2291–8.
   PubMedGoogle Scholar
• White WB, Schulman P, MacCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873–7.
   PubMed Web of Science ®Google Scholar
• Hoegholm A, Kristensen KS, Bang LE, Nielsen JVV, Nielsen WB, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993; 6: 282–6.
   PubMedGoogle Scholar
• Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the Pamela study. J Hypertens 1995; 13: 1377–90.
   Google Scholar
• Pierdomenico SD, Domenico L, Guglielmi MD, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26: 801.
   PubMedGoogle Scholar
• Julius S, Mejia A, Jones K, et al. 'White coat' versus 'sustained' borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16: 617–23.
   PubMed Web of Science ®Google Scholar
• Parving HH, Jensen HAE, Mogensen CE, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; 1: 1190–2.
   PubMed Web of Science ®Google Scholar
• Giaconi S, Levanti C, Fommei E, et al. Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989; 2: 259–61.
   PubMed Web of Science ®Google Scholar
• Schmeider RE, Messerli FH, Garavaglia G, Nunez B. Glomerular hyperfiltration indicates early target organ damage in essential hypertension. JAMA 1990; 264: 2775–80.
   PubMedGoogle Scholar
• Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects: Islington diabetes survey. Lancet 1988; 2: 530–3.
   Google Scholar
• Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. Br Med J 1990; 300: 297–300.
   PubMed Web of Science ®Google Scholar
• Hoegholm A, Bang LE, Kristensen KS, Nielsen JVV, Holm J. Microalbuminuria in 411 untreated individuals with estab-lished hypertension, white coat hypertension, and normo-tension. Hypertension 1994; 24: 101–5.
   Google Scholar
• Gomez-Cerezo J, Rios Blanco JJ, Suarez Garcia I, et al. Noninvasive study of endothelial function in white coat hypertension. Hypertension 2002; 40: 304–9.
   PubMedGoogle Scholar
• Hodis HN, Mack WJ, Labree L, Selzer RH, Liu CR, Azen I. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262–9.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Saba Ps, Pini R, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation 1992; 86: 1909–18.
   PubMed Web of Science ®Google Scholar
• Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A. Evidence for in vivo carotid and femoral wall thickening in human hypertension. Hypertension 1993; 22: 111–8.
   Google Scholar
• Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension. Circulation 1998; 98: 1892–7.
   Google Scholar
• Silveria A, Mesquita A, Maldonado J, Silva JA, PoIonia J. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index. Rev Port Cardiol 2002; 21: 517–30.
   Google Scholar